News & Events
Recent News
Kyowa Hakko Announces Glaxon’s Limited-Time Offer Becomes A Permanent Feature
October 26, 2022New York, NYAfter a resoundingly successful limited-time offering, Glaxon™ has now added Kyowa Hakko’s IMMUSE™ to all SuperGreens Immune formulas. Glaxon™, producer of sports nutrition dietary supplements, launched this summer a SuperGreens Enhanced Immune Edition that, in addition to the power of Glaxon™'s trademarked Supershrooms® Organic Mushroom Blend, included IMMUSE™, a postbiotic that provides immune support at a cellular level - both of which support the immune systems of its customers. Read more »
Cognizin® Citicoline Launches “Tap Challenge” In the App Store
August 8, 2022NEW YORK (PRWEB)The Tap Challenge App is finally here for professional button mashers or anyone who wants to challenge themselves each day! Read more »
Manufacturing strain of Kyowa Hakko Bio’s 2'-fucosyllactose, a human milk oligosaccharide (HMO), passed safety evaluation in China
June 23, 2022KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strain used for producing 2'-fucosyllactose (2’-FL), the most abundant HMO in human milk, has passed the safety evaluation by the Chinese Ministry of Agriculture and Rural Affairs (MARA), while other manufacturing strains used for producing 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) are currently under review. Read more »
Dr. Eri Nakazaki of the Kirin Central Research Institute Wins JSBBA Award for Her Work Developing a Health Food Ingredient to Support Memory
June 1, 2022NEW YORK (PRWEB)One of Kyowa Hakko’s own is honored for the enhancement of citicoline, which helps healthy elderly adults improve memory function Read more »
Kyowa Hakko USA Announces the Appointment of Dr. Colin Hill to the Scientific Advisory Board of Award-Winning Postbiotic IMMUSE™
May 19, 2022NEW YORK (PRWEB)With an impressive background in mining the microbiome for novel therapies, Prof. Hill helped with the definition of a postbiotic as a part of ISAPP. Read more »
Kyowa Hakko USA Announces the Appointment of Dr. Heather Moday as an Educational Partner for IMMUSE™ LC-Plasma
May 12, 2022NEW YORK (PRWEB)With a special interest in immune system dysfunction, including autoimmunity, allergy, and the stress-immune connection, Dr. Moday puts IMMUSE™, an award-winning postbiotic, at the forefront of ingredients to look out for in nutritional supplements. Read more »
Kyowa Hakko USA Announces the Appointment of Gerard Adams as its New President and CEO
April 20, 2022NEW YORK (PRWEB)In his new position, Gerard Adams will be responsible for the growth and development of the company. Read more »
Kyowa Hakko Announces the Results of Three New Consumer Surveys on Consumer Preferences
December 15, 2021PRWeb.comNew consumer surveys reveal supplement users prefer branded ingredients 2x over generic ingredients when making purchasing decisions. Read more »
Kyowa Hakko USA Awarded Best-In-Class Ingredient by Natural Products Insider's Ingredient Idol for its Immune Support Postbiotic, IMMUSE™
November 16, 2021New York, NYHighlighted at the Annual Supply Side West Conference, the Function of Kyowa Hakko’s Novel Postbiotic was recognized as a leader for Immune Health. Read more »
iMUSE Wins 2021 Product of the Year Award in the Immune Support Category at the Nutralngredients-Asia Awards
September 30, 2021Tokyo, JapanKirin Holdings Company, Limited's (Kirin Holdings) iMUSE brand (IMMUSE™ in some markets), won the 2021 Product of the Year Award in the Immune Support category of the Nutralngredients-Asia Awards, held by William Reed Business Media (WRBM), a leading publisher of digital newsletters, publications and data sources for the food, beverage and nutrition industries worldwide. Read more »
Copyright © 1998 – 2022 by KYOWA HAKKO U.S.A., INC. All Rights Reserved. | AWS
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.